Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED Study
Titel:
Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED Study
Auteur:
Sarzi-Puttini, Piercarlo Filippucci, Emilio Adami, Silvano Meroni, Pier Luigi Batticciotto, Alberto Idolazzi, Luca Lucia, Orazio De Talavera, Pablo Kumke, Thomas Grassi, Walter